1H and 13C NMR chemical shifts for ΔCYP107AK1 intermediates i and ii in CD3OD with 0.1% TFA-d (Table S1); LC-HRMS analysis of the purified intermediates i and ii from the S. scabiei ΔCYP107AK1 mutant (Fig. S1); key COSY and HMBC correlations of the purified intermediates i and ii from the S. scabiei ΔCYP107AK1 mutant (Fig. S2); tandem MS spectra and expected fragmentation patterns of the purified intermediates i (Fig. S3) and ii (Fig. S4).
PDF, 805K